Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Tianzhi granule is a traditional Chinese medicine formulation used primarily for the treatment of mild to moderate vascular dementia. It is composed of multiple herbal ingredients and has been evaluated in randomized, double-blind, placebo-controlled phase III clinical trials in China. Clinical studies have shown that Tianzhi granule can improve cognitive function and behavioral and psychological symptoms of dementia (BPSD) in patients with vascular dementia, with efficacy comparable to donepezil and a favorable safety profile. The precise mechanism of action is not fully elucidated but is believed to involve neuroprotective effects through multiple pathways relevant to vascular cognitive impairment[1][4][5].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Tianzhi granule.